Gilead Sciences, Inc. (GILD) Dividend History
Gilead Sciences, Inc. /ˈɡɪliəd/, is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
Last update 09/24/2023
Dividend Yield Summary
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Dividends |
2.28 |
2.52 |
2.72 |
2.84 |
2.92 |
2.25 |
Average Price |
73.80 |
65.67 |
68.82 |
67.64 |
67.04 |
80.12 |
Yield |
3.09% |
3.84% |
3.95% |
4.20% |
4.36% |
2.81% |
• The above Dividend, Average Price, and Yield values for 2023 are year-to-date.
Dividend Dates
Ex Dividend Date |
2023-09-14 |
Dividend Pay Date |
|
DivInfo Metrics ™
52-Week Projected Earnings Per Share |
4.35 |
52-Week Projected Dividends Per Share |
2.90 |
Dividend Cover |
1.50 : 1 |
52-Week Projected Yield |
3.87% |
52-Week Trailing Yield |
3.75% |
6-Year Average Yield |
3.67% |
6-Year Dividend Change |
27.19% |
6-Year Yearly Dividend Change |
4.53% |
Number of Dividend Payments
(2015-06-12 - 2023-09-14)
|
34 |
Dividend History
Date |
Amount Per Share |
Note |
2023-09-14 |
$0.75 |
|
2023-06-14 |
$0.75 |
|
2023-03-14 |
$0.75 |
|
2022-12-14 |
$0.73 |
|
2022-09-14 |
$0.73 |
|
2022-06-14 |
$0.73 |
|
2022-03-14 |
$0.73 |
|
2021-12-14 |
$0.71 |
|
2021-09-14 |
$0.71 |
|
2021-06-14 |
$0.71 |
|
2021-03-12 |
$0.71 |
|
2020-12-14 |
$0.68 |
|
2020-09-14 |
$0.68 |
|
2020-06-11 |
$0.68 |
|
2020-03-12 |
$0.68 |
|
2019-12-12 |
$0.63 |
|
2019-09-12 |
$0.63 |
|
2019-06-13 |
$0.63 |
|
2019-03-14 |
$0.63 |
|
2018-12-13 |
$0.57 |
|
2018-09-13 |
$0.57 |
|
2018-06-14 |
$0.57 |
|
2018-03-15 |
$0.57 |
|
2017-12-14 |
$0.52 |
|
2017-09-14 |
$0.52 |
|
2017-06-14 |
$0.52 |
|
2017-03-14 |
$0.52 |
|
2016-12-13 |
$0.47 |
|
2016-09-14 |
$0.47 |
|
2016-06-14 |
$0.47 |
|
2016-03-14 |
$0.43 |
|
2015-12-14 |
$0.43 |
|
2015-09-14 |
$0.43 |
|
2015-06-12 |
$0.43 |
|